Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Intellia Therapeutics, Inc. | 38,000 | reported | 25 Jul 2017 | tx 1+38,000 |
| Moderna, Inc. | 18,270 | reported | 29 Apr 2020 | tx 2+72,930 |
| Arcturus Therapeutics Holdings Inc. | 15,000 | reported | 09 Jun 2025 | tx 3+44,794 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jun 2025 | GRANT_AWARD | Arcturus Therapeutics Holdings Inc. | 15,000 | 0.00 USD | deriv |
| 19 Jun 2024 | GRANT_AWARD | Arcturus Therapeutics Holdings Inc. | 14,794 | 0.00 USD | deriv |
| 19 Jun 2024 | GRANT_AWARD | Arcturus Therapeutics Holdings Inc. | 15,000 | 0.00 USD | deriv |
| 29 Apr 2020 | GRANT_AWARD | Moderna, Inc. | 18,270 | 0.00 USD | deriv |
| 27 Jun 2019 | GRANT_AWARD | Moderna, Inc. | 54,660 | 0.00 USD | deriv |
| 25 Jul 2017 | GRANT_AWARD | Intellia Therapeutics, Inc. | 38,000 | 0.00 USD | deriv |